Five Things For Pharmacists To Know About The Treatment Of Mycobacterium Tuberculosis
IDStewardship
JUNE 19, 2025
AI-Generated Summary This article by infectious diseases pharmacist Aneeka Chavda outlines five key considerations for pharmacists in the treatment of Mycobacterium tuberculosis (TB), particularly drug-sensitive cases. In 2014, the US FDA approved this regimen, and it features in the latest WHO guidelines for LTBI treatment.
Let's personalize your content